lysergic acid diethylamide has been researched along with Cyanosis in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilapil, VR | 1 |
| Harp, RA | 1 |
| Ehrhardt, OE | 1 |
| Brown, R | 1 |
| Pickering, D | 1 |
2 other studies available for lysergic acid diethylamide and Cyanosis
| Article | Year |
|---|---|
LSD and cyanotic congenital heart disease.
Topics: Abnormalities, Drug-Induced; Cyanosis; Female; Heart Defects, Congenital; Humans; Infant, Newborn; L | 1973 |
Persistent transitional circulation.
Topics: Adult; Cannabis; Cardiac Catheterization; Cyanosis; Diagnosis, Differential; Ductus Arteriosus; Duct | 1974 |